Evidence map›Paper›PMID 28827758›Full record

ArticleScientific reports2017

In vivo label-free structural and biochemical imaging of coronary arteries using an integrated ultrasound and multispectral fluorescence lifetime catheter system.

Julien Bec, Jennifer E Phipps, Dimitris Gorpas, Dinglong Ma, Hussain Fatakdawala, Kenneth B Margulies, Jeffrey A Southard, Laura Marcu

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Precision percutaneous coronary intervention.NPJ cardiovascular health · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Julien BecDepartment of Biomedical Engineering, University of California Davis, Davis, 95616, CA, USA.ORCID 0000-0003-1222-4071
Jennifer E PhippsDepartment of Biomedical Engineering, University of California Davis, Davis, 95616, CA, USA.
Dimitris GorpasDepartment of Biomedical Engineering, University of California Davis, Davis, 95616, CA, USA.ORCID 0000-0001-9576-8087
Dinglong MaDepartment of Biomedical Engineering, University of California Davis, Davis, 95616, CA, USA.
Hussain FatakdawalaDepartment of Biomedical Engineering, University of California Davis, Davis, 95616, CA, USA.ORCID 0000-0003-3007-5575
Kenneth B MarguliesCardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, 19104, PA, USA.
Jeffrey A SouthardUC Davis Health System, Division of Cardiovascular Medicine, University of California Davis, Sacramento, 95817, CA, USA.
Laura MarcuDepartment of Biomedical Engineering, University of California Davis, Davis, 95616, CA, USA. lmarcu@ucdavis.edu.
University of California, Davis · USCardiovascular Institute of the South · USDanaher (United States) · USHelmholtz Zentrum München · DEUC Davis Health · US

Funding

Integrative genomics of human heart failureR01HL105993 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI ASHLEY, EUAN A, CAPPOLA, THOMAS P. · 2011 to 2014
$8.9M
Time-Resolved Spectroscopy of Unstable Arterial PlaquesR01HL067377 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI MARCU, LAURA · 2001 to 2015
$5.2M
NHLBI NIH HHS R01 HL067377NHLBI NIH HHS R01 HL105993
6 · The paper itself

Abstract

Existing clinical intravascular imaging modalities are not capable of accurate detection of critical plaque pathophysiology in the coronary arteries. This study reports the first intravascular catheter combining intravascular ultrasound (IVUS) with multispectral fluorescence lifetime imaging (FLIm) that enables label-free simultaneous assessment of morphological and biochemical features of coronary vessels in vivo. A 3.7 Fr catheter with a fiber-optic channel was constructed based on a 40 MHz clinical IVUS catheter. The ability to safely acquire co-registered FLIm-IVUS data in vivo using Dextran40 solution flushing was demonstrated in swine coronary arteries. FLIm parameters from the arterial wall were consistent with the emission of fluorophores present in healthy arterial wall (collagen, elastin). Additionally, structural and biochemical features from atherosclerotic lesions were acquired in ex vivo human coronary samples and corroborated with histological findings. Current results show that FLIm parameters linked to the amount of structural proteins (e.g. collagen, elastin) and lipids (e.g. foam cells, extracellular lipids) in the first 200 μm of the intima provide important biochemical information that can supplement IVUS data for a comprehensive assessment of plaques pathophysiology. The unique FLIm-IVUS system evaluated here has the potential to provide a comprehensive insight into atherosclerotic lesion formation, diagnostics and response to therapy.

Indexed as

AnimalsCardiac CatheterizationCoronary Artery DiseaseHistocytochemistryHumansOptical ImagingSwineUltrasonography

Identifiers

PMID28827758
PMCPMC5566546
OpenAlexW2748002081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.